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Abstract. E-cadherin is a transmembrane glycoprotein 
that mediates calcium-dependent, homotypic cell-cell 
adhesion and plays an important role in maintaining 
the normal phenotype of epithelial cells. Disruption of 
E-cadherin activity in epithelial cells correlates with 
formation of metastatic tumors. Decreased adhesive 
function may be implemented in a number of ways in- 
cluding: (a) decreased expression of E-cadherin; (b) 
mutations in the gene encoding E-cadherin; or (c) mu- 
tations in the genes that encode the catenins, proteins 
that link the cadherins to the cytoskeleton and are es- 
sential for cadherin mediated cell-cell adhesion. In this 
study, we explored the possibility that inappropriate ex- 
pression of a nonepithelial cadherin by an epithelial cell 
might also result in disruption of cell-cell adhesion. We 
showed that a squamous cell carcinoma--derived cell 
line expressed N-cadherin and displayed a scattered 
fibroblastic phenotype along with decreased expression 
of E- and P-cadherin. Transfection of this cell line with 
antisense N-cadherin resulted in reversion to a normal- 
appearing squamous epithelial cell with increased E- and 
P-cadherin expression. In addition, transfection of a 
normal-appearing squamous epithelial cell line with 
N-cadherin resulted in downregulation of both E- and 
P-cadherin and a scattered fibroblastic phenotype. In 
all cases, the levels of expression of N-cadherin and 
E-cadherin were inversely related to one another. In 
addition, we showed that some squamous cell carcino- 
mas expressed N-cadherin in situ and those tumors ex- 
pressing N-cadherin were invasive. These studies led us 
to propose a novel mechanism for tumorigenesis in 
squamous epithelial ceils; i.e., inadvertent expression of 
a nonepithelial cadherin. 
T 
HE cadherins are members of a large family of trans- 
membrane  glycoproteins  that  mediate  calcium- 
dependent, homotypic cell-cell adhesion and play 
an important role in the maintenance of normal tissue ar- 
chitecture (reviewed in Takeichi, 1990). As the transmem- 
brane component of the adherens junction, they are com- 
posed  of  three  segments:  (a)  an  extracellular  domain 
responsible for cadherin-cadherin interaction; (b) a single- 
pass transmembrane domain; and (c) a  highly conserved 
cytoplasmic domain that  associates  with  actin filaments 
and thus serves to connect the outside of the cell to the cy- 
toskeleton. Cadherins are not bound directly to the actin 
cytoskeleton, but  rather,  are  connected indirectly via  a 
group of proteins known as the catenins. 
The  catenins  were  identified  as  proteins  coimmuno- 
precipitating with the classic cadherins, and were named 
~-catenin, 13-catenin, and ~/-catenin according to their mo- 
bility on SDS-PAGE (Nagafuchi and Takeichi, 1988; Ozawa 
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et al.,  1989; Wheelock and Knudsen, 1991; McCrea et al., 
1991; McCrea and Gumbiner, 1991).  ct-Catenin is a  102- 
kD protein that is associated with the cadherin indirectly 
through its interaction with 13-catenin or ~-catenin. 13-cate- 
nin is a  95-kD  protein that shares ~65  percent identity 
with ~/-catenin  (Fouquet et al.,  1992),  an 82-kD  protein 
also named plakoglobin (Knudsen and Wheelock, 1992; 
Peifer et al., 1992).  13-Catenin and plakoglobin associate 
directly with the cadherin and can substitute for one an- 
other in the cadherin-catenin complex (Butz and Kemler, 
1994; Hinck et al.,  1994; N~ithke et al.,  1994; Sacco et al., 
1995). Thus, the cell-cell adherens junction is a structure 
composed of the transmembrane cadherin, which is associ- 
ated directly with either 13-catenin or plakoglobin, which in 
turn associates directly with a-catenin, ot-Catenin then me- 
diates the interaction between the cadherin-catenin com- 
plex and  the  actin cytoskeleton (Nagafuchi et al.,  1994; 
Knudsen et al., 1995; Rimm et al., 1995). 
Numerous studies have demonstrated the importance of 
the E-cadherin/catenin complex in maintaining the normal 
phenotype of epithelial ceils. Early studies showed that in- 
hibiting E-cadherin activity with function-perturbing anti- 
bodies altered the morphology of MDCK cells and con- 
ferred upon them the ability to invade collagen gels and 
embryonic chicken heart tissue (Behrens et al., 1989; Chen 
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carcinoma cells could be converted to a noninvasive phe- 
notype by transfection with a cDNA encoding E-cadherin 
(Frixen et al., 1991). 
Recently, several studies have reported a correlation be- 
tween decreased function of the E-cadherin/catenin com- 
plex and the formation of human tumors. In some cases, 
decreased adhesive function was caused by decreased levels 
of expression of E-cadherin, and in other cases, by a muta- 
tion in  the  gene encoding E-cadherin such  that  the  ex- 
pressed protein had lost a critical functional domain (re- 
viewed in Blaschuk et al., 1995). Alternatively, decreased 
adhesive function may result from mutations in the genes 
that encode the catenins. For example, mutations in 13-cate- 
nin that disrupt the association of E-cadherin with et-cate- 
nin  resulted in  a  nonadhesive  phenotype (Oyama  et  al., 
1994;  Kawanishi  et  al.,  1995).  In  other  studies,  it  was 
shown that mutations in the gene that encodes ct-catenin 
effectively inactivated E-cadherin function by disrupting 
association of the cadherin complex with the cytoskeleton 
(Hirano et al., 1992; Ewing et al., 1995; Nagafuchi et al., 
1994).  The result was the conversion of tumor cells to a 
metastatic phenotype. Thus, disrupting the function of the 
E-cadherin/catenin complex, independent of the mecha- 
nism of disruption, frequently results in the formation of 
invasive tumorigenic cells. 
In  this  study,  we  explored  the  possibility  that  inap- 
propriate expression of N-cadherin in a squamous epithe- 
lial cell that expresses E-cadherin and P-cadherin might 
also result in a cell with disrupted cell-cell adhesion and a 
more fibroblastic phenotype. We  showed  that  a  squa- 
mous cell carcinoma-derived cell line (UM-SCC-11B) ex- 
pressed N-cadherin and that it had a scattered fibroblastic 
phenotype along with decreased expression of E-cadherin 
and P-cadherin. Transfection of this cell line with antisense 
N-cadherin  resulted  in  reversion  to  a  normal-appearing 
squamous  epithelial cell with increased E-cadherin and 
P-cadherin expression. Interestingly, the levels of expres- 
sion of N-cadherin and both E- and P-cadherin were in- 
versely related  to one  another.  In  addition,  we  showed 
that squamous cell carcinomas did, on occasion, express 
N-cadherin in situ, and that those tumors that expressed 
N-cadherin were invasive. 
Materials and Methods 
Cell Culture 
The human squamous cell carcinoma cultures UM-SCC-1 (SCC1), UM- 
SCC-11A (llA), and UM-SCC-11B (llB) were derived from surgical tu- 
mor specimens of histologically proven squamous cell carcinomas of the 
head and neck, and have been described previously (Baker, 1985).  Cells 
were cultured in MEM supplemented with 10% FCS (Hyclone Laborato- 
ries, Logan, UT) and penicillin/streptomycin, as described (Kimmel and 
Carey, 1986). 
The human fibroblast cell line WI38-VA13 was obtained from Ameri- 
can Type Culture Collection (Rockville, MD)  and maintained in DME 
(GIBCO BRL, Gaithersburg, MD), 10% FCS, and antibiotics (penicillin/ 
streptomycin) at 50 U  penicillin and 50 rag/liter streptomycin (GIBCO 
BRL). 
Antibodies and Reagents 
Unless otherwise stated, all reagents were from Sigma Chemical Co. (St. 
Louis, MO). 
Rat monoclonal (E9) and rabbit polyclonal antibodies against human 
E-cadherin (Wheelock et at., 1987) and mAb against u-catenin (1GS) and 
[3-catenin (12F7;  Johnson et  al.,  1993),  P-cadherin  (6A9;  Lewis et  al., 
1994), and N-cadherin (13A9; Sacco et al., 1995) have been described pre- 
viously. The rabbit polyclonal antibody against a-catenin was purchased 
from Sigma. The mouse monoclonal antibody (HECD1)  against human 
E-cadherin was a gift from Dr. Masatoshi Takeichi (The University of Ky- 
oto, Kyoto, Japan). Tunicamycin was purchased from Calbiochem-Nova- 
biochem Corp. (La Jolla, CA), and a  stock solution (1 mg/ml) was pre- 
pared in DMSO and stored at -70  °. 
Molecular Constructs and Transfection 
The full-length human N-cadherin clone in pBluescript was a gift from Dr. 
John Hemperly (Becton Dickinson Research Center, Research Triangle 
Park,  NC;  Reid  and  Hemperly,  1990).  The  expression vector pLKneo 
(Hirt et al., 1992)  was a gift from Dr. Nicholas Fasel (University of Lau- 
sanne, Lausanne, Switzerland). For expression of full-length N-cadherin, 
the complete eDNA was inserted into pLKneo2. As a control for this ex- 
periment, the pLKneo2 vector without an insert was transfected into cells 
(mock transfection). For  some transfection experiments, the neomycin 
geue in pLKneo was replaced with a  slightly modified puromycin gene 
from pBSpacAp, a  gift from Dr. Juan Ortfn (Universidad Aut6noma de 
Madrid, Madrid, Spain; de la Luna and Ortin,  1992).  This vector is re- 
ferred to as pLKpac, cDNAs inserted into the pLK series of vectors are 
under the control of the mouse mammary tumor virus promoter and are 
inducible by dexamethasone. 
The production of antisense RNA against human N-cadherin used a 
plasmid, mU6, containing a modified human U6 snRNA gene kindly pro- 
vided by Dr. Sarah Noonberg (University of California, San Francisco, 
CA; Noonberg et al., 1994).  A  hybrid U6 gene was created by replacing 
the XhoI/NsiI fragment in mU6 with antisense oligos spanning the start 
codon of human N-cadherin. The hybrid antisense construct was moved 
from mU6 into pBSpacAp as an EcoRI/BamHI fragment. The following 
two oligos were used to make the U6 hybrid gene: oligo-1, 5'-TCGAGTC- 
CCGCTATCCGGCACATGGAGGCGATGCA-Y, and oligo-2, 5'-TCG- 
CCTCCATGTGCCGGATAGCGGGAC-3'  (the  start  codon  is under- 
lined). 
Cell cultures were transfected using a  calcium phosphate kit  (Strat- 
agene, La Jolla, CA) according to the manufacturer's instructions. Colo- 
nies of G-418 or puromycin-resistant cells were isolated and screened for 
expression of the  transfected  gene  by  Western blot  analysis. Positive 
clones were further examined by immunofluorescence. 
Microscopy 
Cells were plated on glass coverslips in MEM with 10% FCS with or with- 
out 107M dexamethasone. For morphological analysis of living cells, the 
coverslips were placed on a glass slide in mounting medium, and pictures 
were taken immediately using the 10× or 40× objective on an Axiophot 
microscope (Carl Zeiss Inc., Thornwood, NY). 
For immunofluorescence,  cells were grown on glass coverslips, fixed for 
30 min in 1% paraformaldehyde buffered with HBSS containing 10 mM 
Hepes, pH 7.4, and permeabilized in methanol at -20°C for 3 rain. Cover- 
slips were blocked with 10% goat serum and 0.1 M glycine in PBS for 20 
min and exposed to antibodies for 1 h, followed by species-specific FITC- 
conjugated secondary antibodies  (Jackson  ImmunoResearch Laborato- 
ries, Inc., West Grove, PA). Fluorescence was detected with a Zeiss Axio- 
phot microscope equipped with epifluorescence. All pictures were taken 
using a 40× objective and T-Max 3200 fill (Eastman Kodak Co., Roches- 
ter, NY). 
Frozen tissue sections of biopsies of squamous cell carcinomas of the 
head and neck were collected from the tumor bank at the University of 
Michigan (Ann Arbor, MI). Tissue sections (8 Ixm) were cut with a cry- 
ostat, placed onto poly-L-lysine-coated slides, and fixed in methanol at 
-20°C for 3 min. Sections were blocked by incubating in PBS containing 
10%  goat serum. Slides were  stained with rabbit  anti-E-cadherin  and 
mouse anti-N-cadherin for 1 h, followed by FITC-conjugated anti-rabbit 
IgG  and rhodamine-conjugated anti-mouse IgG  (Jackson  ImmunoRe- 
search Laboratories). 
Detergent Extraction of Cells 
Monolayers of cells were washed with PBS at room temperature and were 
extracted on ice with 2 ml/75 cm  2 flask 10 mM Tris-acetate, pH 8.0, con- 
The Journal of Cell Biology, Volume 135, 1996  1644 Figure 1.  Morphological analysis of cell lines derived from squamous cell carcinomas. Living cells were photographed using the 10× (A, 
B and C) or 40× objective (a--c). A  and a depict UM-SCC-1 (SCC1); B and b depict UM-SCC-11A (llA); C and c depict UM-SCC-11B 
(liB). Note the normal morphology of SCC1 and the progressively more scattered phenotype of 11A and 11B. Bars, 60 p~m. 
taining 0.5% NP-40 (BDH Chemicals Ltd., Poole, UK), 1 mM EDTA, and 
2 mM PMSF.  Insoluble material was removed by centrifugation at 15,000 
g for 15 min at 4°C. 
Electrophoresis and Immunoblotting 
SDS-PAGE was done as described previously (Johnson et al., 1993). Ma- 
terials  were  from  BioRad  Laboratories  (Richmond,  CA).  Molecular 
weight markers were  from Sigma.  SDS-PAGE-resolved proteins were 
transferred to nitrocellulose and immunoblotted as described (Knudsen 
and Wheelock, 1992), using primary antibodies followed by alkaline phos- 
phatase-conjugated anti-IgG (Promega, Madison, WI) with nitroblue tet- 
razolium and 5-bromo-4-chloro-3-indolyl phosphate substrates.  Protein 
quanfitation was done using the BioRad assay reagent according to the 
manufacturer's suggested protocol. 
Immunoprecipitation 
A 1-ml aliquot of cell extract was mixed with 100 p~l of monoclonal anti- 
body supernatant at 4°C. After 30 min, 100 ~1 of packed anti-mouse IgG- 
Islam et al. N-Cadherin Expression in Squamous Cell Carcinomas  1645 Figure 2.  Expression of cadherins by squamous cell carcinoma--derived cell lines. Cells were grown on glass coverslips and processed for 
immunofluorescence  using mAbs against E-cadherin (Eg) or N-cadherin (13A9). (A, C, and E) The localization of N-cadherin.  (B, D, 
and F) The localization of E-cadherin.  Bar, 60 I~m. 
Sepharose (Organon Teknika-Cappel, Durham, NC) was added, and mix- 
ing was continued for 30 min. The Sepharose-bound immune complexes 
were washed five times with 10 mM Tris-HCl, pH 7.5, 150 mM NaCI, 0.5% 
Tween 20. The pellets were solubilized and resolved by SDS-PAGE. 
Northern Blotting 
Total RNA from SCC-1, llA and 11B was prepared from 100-mm tissue 
culture dishes using RNA Isolator (Genosys Biotechnologies, Inc., Wood- 
lands, TX)  according to the manufacturer's instructions. 20 p~g of total 
RNA from each cell line was electrophoresed on a 1% agarose formalde- 
hyde  gel  and  transferred  to  a  nylon  membrane.  The  membrane was 
probed with [32p]dCTP-labeled 1.1-kh EcoRI fragment of human N-cad- 
herin under high stringency conditions. Bands were visualized by autora- 
diography. 
Results 
Identification  of Squamous Carcinoraa Cells that 
Express N-Cadherin 
Cell lines derived from squamous cell carcinomas of the 
head and neck were examined for cell-cell adhesive char- 
acteristics. Fig. 1 shows the morphology of representative 
cell  lines.  Panels A  and  a  depict  UM-SCC-1  (SCC1),  a 
squamous carcinoma cell line from a tumor of the floor of 
the mouth. SCC1 had a typical squamous cell morphology 
with most cells exhibiting nearly continuous contact with 
surrounding cells. This cell line did not form tumors when 
injected into nude mice (Baker, 1985). Fig. 1, B  and b, de- 
The Journal of Cell Biology, Volume 135, 1996  1646 Figure 3.  Western blot anal- 
ysis  of N-cadherin  in  squa- 
mous  cell  carcinoma- 
derived cell lines.  Confluent 
monolayers of cells were ex- 
tracted  with  NP-40,  and 
equal  amounts  of  protein 
from each  extract  were  re- 
solved  by  7%  SDS-PAGE, 
transblotted  to  nitrocellu- 
lose, and probed with mAbs 
against  N-cadherin  (13A9). 
Lane  1,  control  fibroblasts 
(WI38-VA13); lane 2, SCC1; 
lane 3, llA; lane 4, liB. Mo- 
lecular  weight  markers  are 
indicated. 
pict UM-SCC-11A (llA),  a  cell line derived from a  pre- 
treatment biopsy of squamous cell carcinoma of the larynx 
that was treated with chemotherapy but failed to respond. 
This cell line had a more scattered morphology with much 
less  consistent  cell-cell contacts.  Fig.  1,  C  and  c,  depict 
UM-SCC-11B (llB), a cell line that was derived from the 
laryngectomy specimen of the persistent tumor of the larynx 
from which llA was derived, llB had an even more scattered 
phenotype than llA. The llB cell line was tumorigenic when 
tested in nude mice, while llA grew poorly (Baker, 1985). 
Normal squamous cells of the skin express E-cadherin 
and P-cadherin (Wheelock and Jensen, 1992), so we tested 
the three  squamous cell carcinoma-derived cell lines for 
expression of these proteins. Fig. 2, B, D, and F, shows im- 
munofluorescence staining for E-cadherin. SCC1 (Fig. 2 B) 
expressed levels of E-cadherin that were similar to what we 
typically see in  normal squamous epithelial cells (Whee- 
lock and Jensen, 1992). llA (Fig. 2 D) and liB (Fig. 2 F), 
however, expressed lower levels of E-cadhefin. llB, which 
had an even more scattered phenotype and was isolated 
from a postchemotherapy-recurrent tumor, expressed less 
E-cadherin than did llA. Likewise, SCC1 expressed levels 
of P-cadherin that were similar to normal squamous epi- 
thelial cells, whereas llA  expressed less P-cadherin than 
SCC1 and llB expressed less than llA (data not shown). 
Unexpectedly,  the  more  scattered  cell  lines  expressed 
N-cadherin, a  cadherin that is normally not expressed by 
squamous epithelial cells. Fig. 2, A, C, and E, show immu- 
nofluorescence staining for N-cadherin in SCC1  (A), llA 
(C), and liB (E). In contrast to the E-cadherin expression, 
llB  cells expressed the highest levels of N-cadherin and 
SCC1 expressed the lowest levels of N-cadherin. Western 
blot analysis confirmed these findings. Fig. 3 compares the 
levels of N-cadherin expressed by the fibroblast cell lines 
WI38-VA13  (lane  1),  SCC1  (lane 2),  llA  (lane 3),  and 
liB  (lane  4).  Interestingly, the  N-cadherin  expressed by 
llA  and liB migrated slightly faster on SDS-PAGE than 
did  N-cadherin  from the  fibroblasts. However, Northern 
analysis showed that the messenger RNA encoding N-cad- 
herin from llB cells was the same size as the messenger 
RNA from the fibroblasts (data not shown). Thus, we sus- 
pected that N-cadherin in llA and llB cells was not cor- 
rectly processed. We confirmed with tunicamycin experi- 
ments  that  N-cadherin  in  llA  and  11B  cells  was  not 
properly glycosylated (not shown). 
Figure  4.  Western blot analysis  of E-cadherin and catenins  in 
squamous cell carcinoma--derived  cell lines. Confluent monolay- 
ers of SCC1 cells (lanes 1, 4, and 7), llA cells (lanes 2, 5, and 8), 
and llB cells (lanes 3, 6, and 9) were extracted with NP-40, and 
equal amounts of protein from each extract were resolved by 7% 
SDS-PAGE,  transblotted  to  nitrocellulose,  and  probed  with 
mAbs against E-cadherin (E9, lanes 1-3), et-catenin (1G5, lanes 
4--6), or 13-catenin (12F7, lanes  7-9).  Molecular  weight markers 
are indicated. 
To compare the expression levels of E-cadherin and the 
catenins  in  llA  and  11B  with  SSC1,  we  extracted  cells 
with nonionic detergent, resolved equal amounts of pro- 
tein from each cell line on SDS-PAGE, and immunoblot- 
ted with antibodies against the cadherins and the catenins. 
Fig. 4 shows that SSC1 (lane 1) expressed significantly more 
E-cadherin than did either  llA  (lane 2) or llB  (lane 3). 
Although we could see staining for E-cadherin by immuno- 
fluorescence in all three cell lines, it was not detectable in 
llB by our immunoblotting technique.  When we assayed 
for P-cadherin, we found similar results; SCC1  expressed 
high levels, while llA and llB expressed much lower lev- 
els (data not shown), ct-Catenin and 13-catenin  were more 
abundant in SSC1  (lanes 4  and  7, respectively), but were 
easily  detectable  in  both  llA  (lanes 5  and  8)  and  llB 
(lanes 6 and 9). 
We were equally interested in whether or not the cad- 
herins  (both the normally expressed E- and P-cadherins, 
as well as the aberrantly expressed N-cadherin) were com- 
plexed with catenins in each of the SCC cell lines. To ad- 
dress this question, we immunoprecipitated the cadherins, 
resolved the immunoprecipitation reactions by SDS-PAGE, 
and immunoblotted with a  mixture of anticadherin,  anti- 
et-catenin and anti-13-catenin. Fig. 5 shows that both et-cate- 
nin and 13-catenin  coimmunoprecipitated with E-cadherin 
from SCC1  (lane 1),  llA  (lane 2), and  llB  (lane 3). Al- 
though  liB had much less E-cadherin than the other cell 
lines,  the  E-cadherin  that  was  expressed was  associated 
with catenins.  Likewise, N-cadherin  was complexed with 
catenins  in all three cell lines  (Fig. 5,  lanes 4--6).  As the 
levels of expression of N-cadherin increased in the squa- 
mous cell carcinomas, the levels of both E-cadherin and 
P-cadherin decreased. In all three cell lines, however, the 
Islam et al. N-Cadherin Expression in Squamous Cell Carcinomas  1647 Figure 5.  E-cadherin and N-cadherin are associated with catenins 
in the SCC cell lines. Confluent monolayers of SCC1 cells (lanes 
1 and 4), 11A cells (lanes 2 and 5) and llB cells (lanes 3 and 6 ) 
were extracted with NP-40, and equal amounts of protein from 
each extract were immunoprecipitated with mAbs against E-cad- 
herin (HECD-1, lanes 1-3) or N-cadherin (13A9, lanes 4-6). The 
immunoprecipitation  reactions  were  resolved  by  7%  SDS- 
PAGE, transblotted to nitrocellulose,  and probed with a cocktail 
of mAbs against  et-catenin (ct-cat), 13-catenin (E-cat), and cad- 
herin (E-cadherin in lanes 1-3 and N-cadherin  in lanes 4--6; the 
cadherin is pointed out by an asterisk). In all cases, et-catenin, 
~-catenin,  and cadherin were in the immunoprecipitation reac- 
tions. The levels of cadherin and catenin varied according to how 
much cadherin was expressed by the cell line. The IgG heavy chains 
from the immunoprecipitation reaction are visible at the bottom 
of the gel. Molecular weight markers are indicated. IP, immuno- 
precipitation. 
cadherin was complexed with catenins,  indicating  that  it 
was likely to be functional. 
N-Cadherin Is Expressed by Some Squamous Cell 
Carcinomas  In Vivo 
It was important to determine whether  or not  epithelial 
cells residing within tumors actually expressed N-cadherin 
or if the expression of N-cadherin was an artifact of cul- 
ture. Our prediction was that if N-cadherin was being in- 
appropriately turned on in the tumor, we would be able to 
identify epithelial cells that expressed N-cadherin within 
the tissue. To address this, we surveyed a bank of 47 fro- 
zen squamous cell carcinomas from patients with cancer of 
the head  and neck for coexpression of E-cadherin  (as a 
marker for epithelial  cells)  and  N-cadherin.  Tumor sec- 
tions  were  costained  with  a  rabbit  polyclonal  antiserum 
against E-cadherin and a mouse mAb against N-cadherin. 
The rabbit and mouse antibodies were detected with sec- 
ondary  anti-IgG labeled  with  FITC  and  rhodamine,  re- 
spectively.  In  each  case,  the  squamous  cells  were  uni- 
formly positive for E-cadherin,  as expected for epithelial 
cells. In eight of the tumors, small islands of cells that were 
positive for N-cadherin were observed. Fig. 6 presents two 
representative examples of our survey: A  and C show the 
staining for E-cadherin; B  and D  show colocalization of 
N-cadherin  in  the  sections depicted  in A  and  C,  respec- 
tively.  N-cadherin-positive  cells  are  pointed  out  by  ar- 
rows. Analysis of the  histories  involved in  this  study re- 
vealed that all of the N-cadherin positive tumors showed 
evidence of invasion. 
Transfection  of  N-Cadherin into SCCI Cells Results in 
a Less-adhesive Phenotype 
An important question we wished to address was whether 
or not expression of N-cadherin was likely to be responsi- 
ble for the scattered phenotype of 11A and 11B cells. To 
address  this  question,  we  transfected  full-length  N-cad- 
herin  under  the  control of the  dexamethasone-inducible 
mouse  mammary tumor  virus  (MMTV)  promoter  into 
SCC1  cells.  N-cadherin-expressing  clones  were  selected 
and  observed  for  morphological  characteristics.  Fig.  7 
compares N-cadherin-transfected SCC1 cells (B, b, C, and 
c) with mock-transfected SCC1 cells (A and a). In the ab- 
sence of dexamethasone the transfected cells displayed a 
squamous  cell morphology, as  did  the  mock-transfected 
cells  (B with A)  or the  parent  untransfected  SCC1  cells 
(see Fig.  1 A). When expression was induced with dexa- 
methasone  for  72  h,  however,  a  distinct  morphological 
change became apparent (compare C and c with A  and a); 
the cells began to scatter and to acquire a phenotype more 
like llA  and llB (see Fig. 1, B  and C). Fig. 8 shows that 
the  level  of N-cadherin  expression  increased  when  the 
transfected cells were induced  with dexamethasone, and 
that the level of E-cadheriu decreased concomitantly with 
the increase in N-cadherin. For this figure, we deliberately 
chose to photograph fields that included  cells with good 
cell-cell  contact  to  compare  the  expression  of the  cad- 
herins. Overall, the cells looked identical to those shown in 
Fig. 7. Fig. 8, A  and B, show immunofluorescence staining 
for N-cadherin in uninduced (A) and induced (B) transfec- 
tants. Fig. 8,  C and D, show the expression of E-cadherin 
when  the  cells  are  uninduced  or  induced,  respectively. 
Dexamethasone had no effect on the expression of E-cad- 
herin or N-cadherin in control mock-transfected cells or in 
SCC1 cells (not shown). 
Equal amounts of protein from uninduced and induced 
cultures were immunoprecipitated with antibodies against 
E-cadherin or N-cadherin to analyze the levels of expres- 
sion of the cadherins and to determine whether or not the 
cadherins were complexed with catenins in the transfected 
cells. Fig. 9, lanes 1 and 2, show that the uninduced trans- 
fectant  (lane  1)  expressed more E-cadherin  than the  in- 
duced transfectant (lane 2),  and that the E-cadherin was 
associated with catenins in both cases. Lanes 3 and 4 indi- 
cate a significant increase in the expression of N-cadherin 
in the induced transfectant (lane 4) when compared to the 
uninduced  cells (lane 3).  As  in  the  llB  cells,  the  trans- 
fected N-cadherin was associated with both ot-catenin and 
l~-catenin.  Unlike  the  llB  cells, N-cadherin  appeared to 
be properly processed in  transfected  SCC1  cells since  it 
comigrated on  SDS-PAGE  with  N-cadherin  from fibro- 
blasts (not shown). Thus, the ability of N-cadherin to in- 
duce  a  scattered  phenotype in  squamous  epithelial  cells 
was not caused by its improper processing. 
The Scattered Phenotype of UM-SSC-I1B 
Can be Reversed by Transfection  of  N-Cadherin 
Antisense cDNA 
The experiments discussed above indicate that expression 
The Journal of Cell Biology, Volume 135, 1996  1648 Figure 6.  Expression of N-cadherin by squamous cell carcinomas of the head and neck. Frozen tissue biopsies were sectioned onto poly- 
L-lysine-coated slides and processed for immunofluorescence. Slides were stained with rabbit anti-E-cadherin  plus mouse anti-N-cad- 
herin for 1 h, followed by FITC-conjugated anti-rabbit  IgG plus rhodamine-conjugated anti-mouse  IgG. Pictures were taken using the 
40× objective. (A and C) The localization of E-cadherin in two different tumors. (B and D) The colocalization of N-cadherin in small is- 
lands of cells, which are pointed out by arrows. The bright staining in the upper left hand comer of A (slightly visible in B also) was 
caused by autofluorescence (more prevalent in the FITC channel than in the rhodamine channel), and was seen even in unstained sec- 
tions. Bar, 60 p~m. 
of N-cadherin by squamous epithelial cells can result in a 
more scattered phenotype. However, they do not tell us 
specifically that the phenotype of liB results from the ex- 
pression of N-cadherin. To address this question, we trans- 
fected antisense N-cadherin into llB to decrease the ex- 
pression of N-cadherin by these cells. To obtain high levels 
of expression of the antisense construct, we inserted anti- 
sense oligos into a modified U6 gene; the promoter of U6 
is  constitutively  active  (Noonberg  et  al.,  1994).  Fig.  10 
shows phase contrast micrographs of the transfected cells. 
When compared to the untransfected llB cells (see Figs. 1 
and  7)  the  transfected  cells  had  undergone  a  dramatic 
change  in  morphology.  They  appeared  to  have  much 
closer contacts with one another and a more cohesive, less 
scattered  appearance.  Their  appearance  now closely re- 
sembled that of SCC1  cells  (see Figs.  1 and 7). Western 
blot  analysis  (Fig.  11)  showed  that  the  antisense-trans- 
fected llB cells expressed less N-cadherin (compare lane 
4 with lane 3) and more E-cadherin (compare lane 2 with 
lane 1) than did the parent llB cells. Immunofluorescence 
microscopy confirmed these data.  Fig.  12 A  shows that 
N-cadherin was barely detectable in  the  antisense-trans- 
fected llB ceils.  Fig. 12 B  shows that E-cadherin expres- 
sion  was  upregulated  in  the  antisense-transfected  llB 
cells,  and that it was localized at cell-cell borders. These 
results were not caused by clonal variation in the llB cell 
line, since we obtained identical results with several differ- 
ent clones. 
Thus, we have presented data that strongly suggest that 
inappropriate expression of a nonepithelial cadherin in a 
squamous epithelial cell line resulted in a cell with a more 
scattered  and  less  adhesive  phenotype.  In  addition,  we 
have shown that N-cadherin was, on occasion, expressed 
by epithelial cells in squamous cell carcinomas of the head 
and neck, and that there was a high probability of invasion 
in those tumors with N-cadherin-positive cells. Finally, we 
have shown that a scattered squamous cell carcinoma can 
revert to a cell with a classical epithelial morphology when 
transfected with antisense  to N-cadherin, indicating that 
the scattered phenotype is a direct result of expression of 
N-cadherin. Interestingly, E-cadherin and N-cadherin ex- 
pression were reciprocally coregulated in these cells. 
Discussion 
In the present study, we have shown that inappropriate ex- 
Islam et al. N-Cadherin Expression in Squamous Cell Carcinomas  1649 Figure 7.  Transfection of SCC1 cells with N-cadherin resulted in a more scattered phenotype. SCC1 cells were transfected with N-cad- 
herin under the control of a dexamethasone-inducible promoter. Living cells were photographed using the 10× (A-C) or 40× (a-c) ob- 
jective. A and a show SCC1 cells mock transfected with the vector without an insert (cont) treated with dexamethasone for 72 h as con- 
trois for morphological changes. B, b, C, and c show the transfected cells without (-dex) and with (+dex) dexamethasone for 72 h. Note 
the change in morphology when the transfected cells are induced with dexamethasone. Bars, 60 ~m. 
pression of N-cadherin by epithelial cells can result in cells 
with the more scattered, less adhesive phenotype, which is 
typical of  invasive  tumor  cells.  Numerous  studies  have 
shown  that disruption of the E-cadherin/catenin complex 
in  epithelial cells results in biologically aggressive tumor 
cells,  implicating E-cadherin  as  the  product  of  a  tumor 
suppressor gene (Vleminckx et al., 1991; Navarro et al., 1991; 
Frixen et  al.,  1991;  Umbas  et  al.,  1992;  Schipper  et  al., 
1991; Pierceall et al., 1995; Berx et al., 1995; reviewed in 
Takeichi, 1993).  Such studies have shown  that  mutations 
or deletions that affect the function of the cadherin or one 
of the  catenins contribute to the tumorigenic phenotype. 
The Journal of Cell Biology, Volume 135, 1996  1650 Figure 8.  Expression of E-cadherin and N-cadherin in SCC1 cells transfected with N-cadherin. Transfected cells were grown on glass cov- 
erslips without (A and C) or with (B and D) dexamethasone, and were processed for immunofluorescence  using mAbs against N-cad- 
herin (13A9, A and B) or E-cadherin (E9, C and D). Note the increase in N-cadherin  and concomitant decrease in E-cadherin expres- 
sion when the cells are induced with dexamethasone. Bar, 60 Ixm. 
Regardless of the mechanism of disruption,  whether it is 
caused by a  deletion in c~-catenin or  13-catenin  such that 
the cadherin complex cannot interact with actin filaments, 
or by a mutation or deletion in the cadherin itself so that it 
cannot function as an adhesion molecule, the result is sim- 
ilar; the cells are more likely to become invasive. It is un- 
expected and interesting that a  similar phenotype is seen 
in  cells that  express  an  inappropriate  cadherin,  perhaps 
suggesting that an epithelial/mesenchyme transition remi- 
niscent  of  those  seen  during  some  developmental  pro- 
cesses may be inadvertently activated in these cells. 
The cadherins are members of a large family of related 
proteins.  Epithelial  cells  express  primarily  E-cadherin 
alone or E-cadherin and P-cadherin,  although other cad- 
herins  have  been  demonstrated  in  some  epithelial  cells. 
Neurons,  mesothelial  cells,  muscle,  lens  epithelial  cells, 
and fibroblasts express N-cadherin. N-cadherin can func- 
tion  as a  respectable adhesion molecule; for example, in 
cardiac muscle, N-cadherin plays an essential role in the 
formation of strong cell-cell contacts that allow the cells to 
beat coordinately (Volk and  Geiger,  1984;  Peralta  Soler 
and Knudsen,  1994).  In addition,  tissues such as the me- 
sothelium  and  the  lens  use N-cadherin  to  form contacts 
that  very much  resemble  the  E-cadherin-mediated  con- 
tacts  of epithelial  ceils  (Volk  and  Geiger,  1984;  Peralta 
Soler et al., 1995).  However, N-cadherin is also expressed 
by cells such as fibroblasts that do not display close cell- 
cell contacts, but rather,  act as solitary cells most of the 
time. Fibroblasts and cardiac muscle cells express approxi- 
mately equal  levels of N-cadherin,  and  the  N-cadherin/ 
catenin complex in these two cell types appears to be iden- 
tical (Wheelock and Knudsen,  1991; Knudsen et al.,  1995); 
however,  the  adhesive  characteristics  of  these  two  cell 
types is quite different. It is not clear why expression of 
N-cadherin by squamous epithelial cells is not compatible 
with the typical epithelial cell morphology. One could ar- 
gue that the dramatic difference in the morphology of epi- 
thelial cells and fibroblasts is the presence of desmosomes. 
Theoretically, squamous epithelial cells should be able to 
make desmosomes, even when E-cadherin is replaced by 
N-cadherin, since cardiac muscle cells that express N-cad- 
herin make desmosomes. Our hypothesis is that it is a dif- 
ference in signaling capabilities of the individual cadherins 
rather than the physical ability of the cadherin to mediate 
adhesion that contributes to the difference in phenotype 
when squamous epithelial cells express N-cadherin rather 
than  E-cadherin.  We  are  currently addressing  this  ques- 
tion using chimeric E-cadherin/N-cadherin molecules. 
Islam et al. N-Cadherin Expression in Squamous Cell Carcinomas  1651 Figure 9.  Catenins  were associated with N-eadherin in the trans- 
fected SCC1 cells. Confluent monolayers of SCC1 cells trans- 
fected with N-cadherin,  either uninduced  (-) or induced  (+), 
were extracted with NP-40, and equal amounts of protein from 
each extract were immunoprecipitated with mAbs against E-cad- 
herin (HECD-1, lanes I and 2) or N-cadherin (13A9, lanes 3 and 4). 
The immunopreeipitation reactions were resolved by 7% SDS- 
PAGE, transblotted to nitrocellulose,  and probed with a cocktail 
of mAbs against  et-eatenin  (a-cat),  I~-catenin (13-cat), and cad- 
herin (E-cad in lanes I and 2 and N-cad in lanes 3 and 4; the cad- 
herin is pointed out by an asterisk). In all cases, a-eatenin, 13-cate- 
nin,  and  cadherin  were in  the  immunoprecipitation reactions. 
When N-cadherin expression  was induced  (lanes 2  and 4), the 
level  of N-cadherin  increased  and the level of E-cadherin de- 
creased. Molecular weight markers are indicated. 
We became interested in cells derived from squamous 
cell carcinomas when we discovered that some squamous 
cell carcinoma-derived cell lines expressed N-cadherin. In 
fact, even the normal-appearing cells with high levels of 
E-cadherin and P-cadherin expressed a  small amount of 
N-cadherin.  It has not been determined whether normal 
squamous epithelial cells express small amounts of N-cad- 
herin. One possibility is that squamous epithelial cells al- 
ways express trace  levels of N-cadherin,  and  the  tumor 
cells have inadvertently turned on higher levels of expres- 
sion that resulted in the observed phenotype. It appears 
that  the  scattered  phenotype  is  directly  caused  by  in- 
creased N-cadherin expression because we could mimic it 
in  the  laboratory simply by transfecting N-cadherin  into 
normal-appearing squamous  epithelial  cells.  Even  stron- 
ger evidence for N-cadherin being the cause of the scat- 
tered phenotype was obtained when the phenotype of lIB 
cells reverted to  a  more normal adhesive squamous cell 
appearance  after  transfection  with  an  N-cadherin  anti- 
sense construction. It is not known whether the change in 
phenotype of the N-cadherin-expressing cells is caused di- 
rectly by N-cadherin or by the resultant decrease in E-cad- 
herin expression. 
It appears that E-cadehrin and N-cadherin levels are re- 
ciprocally regulated  in squamous epithelial cells.  When 
N-cadherin  was ectopically expressed in  SCC1  cells,  the 
levels of E-cadherin decreased; when N-cadherin expres- 
Figure  10.  Transfection  of  llB  with  antisense  N-cadherin  re- 
sulted in a cell line with a normal squamous epithelial  cell mor- 
phology. The llB cell line was transfected with antisense  N-cad- 
herin, and hving cells were photographed using the 10× objective 
(A) or the 40× objective (B). Note the normal morphology of the 
transfected cells. Bars, 60 Ixm. 
sion in llB was decreased by introduction of an antisense 
construct,  the  levels  of  E-cadherin  and  P-cadherin  in- 
creased dramatically. The mechanism of this coregulation 
is not understood. However, there are several examples of 
coregulation  of cadherin levels during development. For 
example, in two major morphogenetic events, gastrulation 
and  neurulation,  cells that  segregate from the  ectoderm 
gradually cease to express E-cadherin and begin to express 
N-cadherin  (Takeichi,  1987).  Recently,  it  was  suggested 
that reciprocal expression of E-cadherin and cadherin-ll 
may play a role in trophoblast-endometrial cell interactions 
during implantation of the mammalian embryo (MacCal- 
man et al., 1996). Perhaps expression of N-cadherin by squa- 
mous cell carcinomas facilitates cells leaving the site of the 
tumor and invading the underlying stroma, where they are 
compatible with stromal N-cadherin-expressing cells. 
It will be interesting to examine the SCC1 and liB cells 
along with the transfectants for expression of other adhe- 
sion molecules. For example, several recent studies have 
suggested  that  integrin  expression  and  cadherin  expres- 
sion may be coregulated (Hodivala and Watt, 1994; Burd- 
sal et al., 1993) in some systems. We are currently investi- 
gating  changes  of expression  of integrins  by SCC1  and 
The Journal  of Cell Biology,  Volume 135, 1996  1652 Figure  11.  Expression  of 
cadherins  in 11B cells trans- 
fected with  antisense  N-cad- 
herin.  Confluent monolayers 
of llB cells (lanes I and 3) or 
liB cells transfected with an- 
tisense  N-cadherin  (lanes  2 
and  4)  were  extracted  with 
NP-40, and equal amounts of 
protein  from  each  extract 
were  resolved by 7%  SDS- 
PAGE, transblotted to nitro- 
cellulose,  and  probed  with 
mAbs  against  E-cadherin 
(HECD1, lanes  1 and 2),  or 
N-cadherin  (13A9,  lanes  3 
and 4). Note the increase  in 
E-cadherin  when  N-cad- 
herin  expression  was  de- 
creased.  Molecular  weight 
markers are indicated. 
SCCllB upon transfection of N-cadherin and N-cadherin 
antisense constructs, respectively. 
In addition  to the interesting cell biology, there is also 
significant clinical relevance to our findings. All of the tu- 
Figure 12.  Localization  of cadherins  in 11B cells transfected with 
antisense  N-cadherin.  Transfected 11B cells were grown on glass 
coverslips  and processed for immunofluorescence using  mAbs 
against N-cadherin (13A9, A) or E-cadherin (E9, B). Note the in- 
crease in E-cadherin and the concomitant decrease in N-cadherin 
expression. Bar, 60 I~m. 
mors that  included  N-cadherin-positive colonies  of cells 
were found to subsequently invade the surrounding tissue. 
In addition, the SCC1 cell line failed to produce tumors in 
nude mice, llA  grew poorly in nude mice, and lIB grew 
well in  vivo (Baker,  1985).  Together, these  data  suggest 
that there  is a  correlation  between expression of N-cad- 
herin by squamous epithelial cells and the ability of these 
cells to form tumors in nude mice and to invade the sur- 
rounding tissue. We would like to suggest that expression 
of N-cadherin by squamous epithelial cells may be an indi- 
cator of a potentially aggressive tumor. However, a much 
larger clinical study is needed to confirm this. We would 
also  like  to suggest that  in  addition  to examining tumor 
cells for mutations in the adhesion molecules they would 
normally express,  it  may  also  be  important  to  examine 
them for inappropriate expression of other adhesion mole- 
cules. 
It is interesting that E-cadherin expression is not perma- 
nently lost in E-cadherin-negative squamous cell carcino- 
mas,  since  blocking N-cadherin  expression  upregulated 
E-cadherin.  This  would  suggest  that  further  studies  are 
needed  to  elucidate  the  mechanisms  that  regulate  cad- 
herin expression and the switch from one cadherin. Eluci- 
dation  of physiological or  environmental  molecules  that 
may regulate this switch could provide clues to effective 
treatment or prevention of squamous cell carcinomas. 
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